Technology Forum Life Sciences 2024

The European House - Ambrosetti launched in 2015 the Technology Forum Life Sciences, the event of maximum visibility of the Life Sciences Community, the multistakeholder platform for discussion and discussion on life sciences that has the mission of "to contribute to the enhancement of the ecosystem of research and innovation in the field of Life Sciences in Italy, promoting centres of excellence and networking national stakeholders to promote knowledge transfer, the development of new projects and improve the positioning and competitiveness of the country-system at international level".

The Technology Forum Life Sciences 2024 marks the 10th anniversary of the Community. On this occasion, the Forum will promote a high-level debate among the main players in the sector: top executives of Life Sciences companies, research centres and universities, Venture Capital and Private Equity funds, representatives of the Italian and European institutions. The performance of the Italian innovation ecosystem will be analyzed in a comparative way with European ecosystems (in terms of scientific production, technology transfer, startups and spinoff, research investments).

The global R&D trends in Life Sciences will also be presented. Finally, the comparison with Italian and European policy makers will be stimulated, to understand what are the main actions to be taken to improve the performance and positioning of the Italian ecosystem of research and innovation in the sector.

On the occasion of the Forum, the Community Life Sciences will also present the results of the new edition of the White Paper on Life Sciences in Italy, which each year examines the state of research and industry in the field, analyzing the performance of our country in the international context and the new global innovation trends.

The speakers: 

• Laura Baranello, Group Leader and Principal Researcher, Karolinska Institutet; Recipient of the 2022 ERC Consolidator Grant
• Niresh Berinpanathan, Associate, Nextech Invest
  
• Magda Bienko, Group Leader at the Functional Genomics Centre, Human Technopole; Recipient of the 2022 ERC Consolidator Grant
• Valerio De Molli, Managing Partner and CEO, The European House - Ambrosetti
• Thomas Geninatti, Senior Director Corporate Development, Gilead Sciences
  
• Tony Hickson, Chief Business Officer, Cancer Research UK; Advisor, Cambridge Enterprise
• Sarah Kerruish, Chief Strategy Officer, Kheiron Medical
• Lev Kogon, Vice President, Head of Business Development, Nykode Therapeutics
  
• Antonio Lanzavecchia, Senior Vice President and Senior Research Fellow, Vir Biotechnology; Invernizzi Fellow, Human Immunology Program, Istituto Nazionale di Genetica Molecolare
• Filippo Mulinacci, Chief Business Officer, Araris Biotech
  
• Francesca Pasinelli, General Director, Fondazione Telethon
• Gregg L. Semenza, 2019 Nobel Prize Laureate in Medicine; Professor of Genetic Medicine, Johns Hopkins University; Director of Vascular Program, Johns Hopkins Institute for Cell Engineering
  
• Ennio Tasciotti, Professor of Biotechnologies, Università San Raffaele Roma; Director Human Longevity Program, IRCCS San Raffaele Roma
• Gianmario Verona, President, Fondazione Human Technopole
  
  

The Forum will be chaired by Mariavittoria Zaglio, Journalist, Class CNBC - Sanità Next



For further information about the Forum:

hub.innotech@ambrosetti.eu